TABLE 1.
Accumulated dose of CLO and TBI-166 during the 2 studies
| Accumulated dose during the study, total mg/kg at the end of the study |
||||
|---|---|---|---|---|
| 1st 2 wks | wk 4 | wk 8 | wk 12 (study 2) | |
| QD | 200 | 400 | 800 | 1,200 |
| TIW | 200 | 320 | 560 | 800 |
| BIW (study 2) | 200 | 280 | 440 | 600 |
Accumulated dose of CLO and TBI-166 during the 2 studies
| Accumulated dose during the study, total mg/kg at the end of the study |
||||
|---|---|---|---|---|
| 1st 2 wks | wk 4 | wk 8 | wk 12 (study 2) | |
| QD | 200 | 400 | 800 | 1,200 |
| TIW | 200 | 320 | 560 | 800 |
| BIW (study 2) | 200 | 280 | 440 | 600 |